×







We sell 100% Genuine & New Books only!

Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill 2019 Edition at Meripustak

Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill 2019 Edition by Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman , Springer

Books from same Author: Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 10372.00/- [ 21.00% off ]

    Seller Price: ₹ 8194.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman
    PublisherSpringer
    ISBN9789811353697
    Pages275
    BindingPaperback
    LanguageEnglish
    Publish YearJanuary 2019

    Description

    Springer Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill 2019 Edition by Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman

    This book provides unique insights into the issues that drive modified dosing regimens for antibiotics in the critically ill. Leading international authors provide their commentary alongside a summary of existing evidence on how to effectively dose antibiotics.Severe infection frequently necessitates admission to the intensive care unit (ICU). Equally, nosocomial sepsis often complicates the clinical course in ICU. Early, appropriate application of antibiotic therapy remains a cornerstone of effective management. However, this is challenging in the critical care environment, given the significant changes in patient physiology and organ function frequently encountered. Being cognisant of these factors, prescribers need to consider modified dosing regimens, not only to ensure adequate drug exposure, and therefore the greatest chance of clinical cure, but also to avoid encouraging drug resistance.



    Book Successfully Added To Your Cart